Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells
Open Access
- 20 January 2022
- Vol. 71 (12), 2526-2538
- https://doi.org/10.1136/gutjnl-2021-324478
Abstract
Objective Mucosal-associated invariant T (MAIT) cells are the most abundant T cells in human liver. They respond to bacterial metabolites presented by major histocompatibility complex-like molecule MR1. MAIT cells exert regulatory and antimicrobial functions and are implicated in liver fibrogenesis. It is not well understood which liver cells function as antigen (Ag)-presenting cells for MAIT cells, and under which conditions stimulatory Ags reach the circulation. Design We used different types of primary human liver cells in Ag-presentation assays to blood-derived and liver-derived MAIT cells. We assessed MAIT cell stimulatory potential of serum from healthy subjects and patients with portal hypertension undergoing transjugular intrahepatic portosystemic shunt stent, and patients with inflammatory bowel disease (IBD). Results MAIT cells were dispersed throughout healthy human liver and all tested liver cell types stimulated MAIT cells, hepatocytes being most efficient. MAIT cell activation by liver cells occurred in response to bacterial lysate and pure Ag, and was prevented by non-activating MR1 ligands. Serum derived from peripheral and portal blood, and from patients with IBD stimulated MAIT cells in MR1-dependent manner. Conclusion Our findings reveal previously unrecognised roles of liver cells in Ag metabolism and activation of MAIT cells, repression of which creates an opportunity to design antifibrotic therapies. The presence of MAIT cell stimulatory Ags in serum rationalises the observed activated MAIT cell phenotype in liver. Increased serum levels of gut-derived MAIT cell stimulatory ligands in patients with impaired intestinal barrier function indicate that intrahepatic Ag-presentation may represent an important step in the development of liver disease.Keywords
Funding Information
- Swiss Life Jubiläumsstiftung (Not applicable)
- Swiss National Science Foundation (PZ00P3_167828, PZ00P3_189490)
- Goldschmidt-Jacobson Stiftung (Not applicable)
- Julia & Gottfried Bangerter-Rhyner Stiftung (Not applicable)
- Cancer Research Institute (Not applicable)
- NIHR Biomedical Research Centre, Oxford (Not applicable)
- Nora van Meeuwen-Häfliger Stiftung (Not applicable)
- Vontobel Stiftung (Not applicable)
- Olga Mayenfisch Stiftung (Not applicable)
- Freie Akademische Gesellschaft Basel (Not applicable)
- Wellcome Trust (109965MA)
- Uniscientia Stiftung
This publication has 45 references indexed in Scilit:
- MAIT Cells Detect and Efficiently Lyse Bacterially-Infected Epithelial CellsPLoS Pathogens, 2013
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gutJournal Of Physiology-London, 2012
- Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8α+ semi-invariant T cellsBlood, 2011
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cellsBlood, 2011
- Antimicrobial activity of mucosal-associated invariant T cellsNature Immunology, 2010
- Analysis of CD161 expression on human CD8+T cells defines a distinct functional subset with tissue-homing propertiesProceedings of the National Academy of Sciences of the United States of America, 2010
- Non-invasive assessment of barrier integrity and function of the human gutWorld Journal of Gastrointestinal Surgery, 2010
- Hepatic Interleukin-7 Expression Regulates T Cell ResponsesImmunity, 2009
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2001